Drugs / autologous bone marrow-derived progenitor cells
autologous bone marrow-derived progenitor cells
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT00711542 Comparator | Sep 2008 → Dec 2014 | acute myocardial infarction, coronary artery disorder | Johann Wolfgang Goethe University Hospital | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | autologous bone marrow-derived progenitor cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00711542 ↗ |
| Modality | Cell therapy | “autologous bone marrow-derived progenitor cells” NCT00711542 ↗ |
| Route | Other | “intracoronary infusion of autologous bone marrow-derived progenitor cells” NCT00711542 ↗ |